Bibaswan Biswas

Dr. Bibaswan Biswas

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Indian Journal of Research in Homoeopathy
Verified
Journal Article
Open access
PDF file
AGAbanti Goswami
Abanti Goswami
NGNarasimha Kumar G.V
Narasimha Kumar G.V
VSVara Prasad Saka
Vara Prasad Saka
PGPankaj Gupta
Pankaj Gupta
BBBibaswan Biswas
Bibaswan Biswas
DVDigvijay Verma
Digvijay Verma
Background: Rhus toxicodendron (Rhus tox.) is a well-known homoeopathic medicine used to treat inflammatory disorders supported by historical and modern scientific evidence. Objective: The safety testing of 6C, 30C and 200C potencies of Rhus tox. through acute and sub-acute oral toxicity tests as per the Organisation for Economic Cooperation and Development test guidelines. Methods: For the acute oral toxicity study, Rhus tox. (2000 μL/kg) was administered to rats and observed for 14 days. For the subacute oral toxicity study, Rhus tox. (200 μL/kg) was administered for 28 days and additional recovery groups were included to monitor reversibility, persistence, or delayed occurrence of toxic effects for 14 days post-treatment. Histopathological assessments of vital organs were done to detect any signs of toxicity. Results: No mortality occurred during the acute toxicity study at a dose of 2000 μL/kg, indicating an oral LD50 of Rhus tox. >2000 μL/kg. In the sub-acute toxicity study, Rhus tox. administration for 28 days showed no adverse clinical signs, with normal weight gain and feed intake in treated animals. No adverse changes were noticed in the biochemical and haematological parameters of Rhus tox. treated rats. Furthermore, no abnormalities were observed in gross and histopathological examinations of vital organs. Conclusion: The study found that Rhus tox. in 6C, 30C and 200C potencies exhibited a safe toxicological profile, supporting its beneficial pharmacological effects.

7 August 2023 in Homœopathic Links
Verified
Journal Article
Closed access
PDF file
BBBibaswan Biswas
Bibaswan Biswas
SMSatyajit Maity
Satyajit Maity
KBKaushik Bhar
Kaushik Bhar
SSSudeshna Sett
Sudeshna Sett
NGNarasimha Kumar G.V
Narasimha Kumar G.V
Introduction Damiana has been used as aphrodisiac in ethnomedicine for centuries. However, the use of Damiana in homeopathy is diverse, e.g. for migraine treatment of, amenorrhoea, spermatorrhoea, urinary tract infection and prostate related issues. However, this medicinal plant is non-native to India. Hence, it is imperative to investigate the quality of the medicine samples available and prepared in India. Hence, we undertook in-depth chemical analysis of the raw drugs and the commercially available samples of this medicine. Materials and Methods The reported chemical study includes determination of the physicochemical parameters of the raw drug involving, foreign matter, loss on drying, extractive values in different solvents, ash values total fixed oil and total volatile oil. Also, the study includes the analysis of the in-house and commercial mother tinctures consisting of, pH, organoleptic parameters, total solids, total phenol content, ultraviolet absorption spectroscopy and high performance thin layer chromatography. Phytochemical screening of the mother tinctures and extracts of the raw drugs in different solvents was done. A preliminary molecular docking study was done to evaluate the applicability of apigenin as the homoeopathy-specific marker. Result In-house mother tincture, mother tinctures from Indian and multinational companies show similar quality. Molecular docking revealed that apigenin may be a good candidate for homoeopathy-specific marker. Conclusion Our study provides pharmacopoeial standards which show that even for exotic plants the quality of mother tinctures from Indian and international companies is similar.

29 September 2023 in Indian Journal of Research in Homoeopathy
Verified
Journal Article
Open access
PDF file
BBBibaswan Biswas
Bibaswan Biswas
SMSatyajit Maity
Satyajit Maity
ESEn Sundaram
En Sundaram
NGNarasimha Kumar G.V
Narasimha Kumar G.V
SPSatish Patel
Satish Patel
Background: Unlike the mainstream biomedical system, honeybees’ therapeutic use has long been well documented in the homoeopathic system. The medicine prepared from the whole honeybee, Apis mellifica, is on the Essential Drug List. Objective: An in-depth physicochemical standardisation of this homoeopathic drug is attempted. Material and Methods: In this study, first the raw drug was authenticated, and then its pharmacopoeial parameters were measured, e.g. moisture content, foreign matter, different ash values, alcohol and water-soluble extractive values. Further, the mother tincture of Apis mellifica was prepared from the authentic raw drug. The pharmacopeial parameters of in-house mother tincture and a commercial mother tincture, e.g. organoleptic parameters, sediment detection, specific gravity measurement, pH measurement, total solids measurement, qualitative ultraviolet-visible spectra determination and high-performance thin layer chromatography were carried out for in-depth standardisation. Results: This study provides the standards for the aforementioned pharmacopeial parameters of Apis mellifica using pharmacopeial procedures. For the first time, the quantitative data obtained here quantifies those pharmacopeial parameters. The comparative study of the parameters of the in-house mother tincture and commercial sample shows the significance of the reported work for maintaining the high quality of the drugs. Conclusion: The data presented here could be used for updating the pharmacopeial standards and limits for the homoeopathic drug Apis mellifica in the future.

7 May 2025 in Homœopathic Links
Verified
Journal Article
Closed access
PDF file
BBBibaswan Biswas
Bibaswan Biswas
SMSatyajit Maity
Satyajit Maity
PMPaulami Majumdar
Paulami Majumdar
GCGurudev Choubey
Gurudev Choubey
ASArti Soren
Arti Soren
Yucca filamentosa is primarily used in homeopathy for treating gastric ailments, supported by its saponin content. Despite being exotic to India with limited availability, its mother tincture is widely accessible in the country. Given these factors, assessing the quality of these medicines in India is crucial. Therefore, alongside pharmacopeial standardization, a comparative chemical profiling study was conducted on mother tinctures sourced from plants grown in India (OM), those produced in India (IM), and those manufactured abroad (AM).The pharmacopeial parameters of the raw drug, such as loss on drying, different ash values, extractive values in various solvents, and volatile oil content, were measured. Additionally, phytochemical screening of the raw drug in different extractive solvents was performed. Subsequently, the physicochemical parameters including organoleptic characteristics, sediments, total solids, and ultraviolet–visible absorption spectra of OM, IM, and AM were compared. Further comparative phytochemical screening and qualitative high-performance thin-layer chromatography (HPTLC) analysis were conducted.The pharmacopeial data for the raw drug were reported for the first time. The comparative study on the mother tinctures OM, IM, and AM revealed significant chemical differences.The comparison of the three mother tinctures (OM, IM, and AM) highlighted substantial chemical variations, underscoring the need for more rigorous chemical and biological evaluations.

29 October 2026 in Molecules
Verified
Journal Article
Open access
PDF file
TDTotan Das
Totan Das
IBIshita Biswas
Ishita Biswas
SMSatyajit Maity
Satyajit Maity
SMSayani Maji
Sayani Maji
KKK. Karunaidhasan
K. Karunaidhasan
BBBibaswan Biswas
Bibaswan Biswas
Background/Objectives: Ocimum tenuiflorum (OT) exhibits diverse therapeutic effects linked to its antioxidant activity. Studies integrating phytochemical variability, functional antioxidant localization, and chemometric evaluation of Pharmacopeia-Relevant Extracts (PREs) remain limited. This study investigated phytochemical variability and antioxidant-associated profiling among PREs of OT from geo-climatic regions and commercial sources. Methods: PREs were investigated through High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting, HPTLC-2,2-diphenyl-1-picrylhydrazyl (DPPH) bioautography, HPTLC quantification, Total Phenolic and Flavonoid Content (TPC and TFC), DPPH-IC50 and Ferric Reducing Antioxidant Power (FRAP) assays, correlation statistics, and chemometric analyses. Results: Rosmarinic acid (RA) and ursolic acid (UA) were detected across all PREs; eugenol was not detected but detected in non-polar extracts. HPTLC-DPPH bioautography exhibited antioxidant-associated localization for RA but not UA. RA concentration, TPC, TFC, DPPH-IC50, and FRAP showed substantial variability among PREs. RA correlated more strongly than TPC with antioxidant endpoints: positively with FRAP and inversely with DPPH-IC50; TFC correlated non-significantly with the dataset. Geo-climatic variability was linked to differences in RA, TPC, IC50, and FRAP, with TFC not reaching significance, and varietal differences remained non-significant. Chemometric analyses demonstrated distinguishable clustering among PREs. Conclusions: This study highlights observational trends in geo-climatic phytochemical variation, identifying RA as a major antioxidant-associated marker under the present conditions.